Exclusive Q&A with Pharmacovigilance Expert at Pharmacovigilance, Drug Safety & Risk Management 2015

SMi’s 4th annual Pharmacovigilance, Drug Safety & Risk Management conference takes place in just 4 weeks’ time on the 11th – 12th May 2015 at the Holiday Inn Regents Park Hotel in London, UK.
 
 
Pharmacovigilance, Drug Safety & Risk Management 2015
Pharmacovigilance, Drug Safety & Risk Management 2015
LONDON - April 21, 2015 - PRLog -- The CPD certified event on pharmacovigilance good practice and drug safety has attracted a global audience of market specialists and regulatory experts to explore the latest developments in PV guidelines and European drug safety laws, as well as address the challenges of under-reporting and patient safety.

This years summit includes 17 industry led presentations, 17 hours of compelling content, 1 topical panel, 5 hours of networking and 2 interactive workshops.

Case studies will include a presentation by Bluefish Pharmaceuticals, Head of Pharmacovigilance and QPPV, Dr Julia Appelskog.

"During my presentation I will provide practical examples of how to address various issues and what are the expectations from inspectors."

Dr Appelskog quoted the PRAC keynote address by Doris Irene Stenver as one of the highlights of the show.

"Doris is an excellent presenter and I am genially interested in the topic of internationalization...I am surprise to see how little information is available within the PV field and how much work is initiated within the Regulatory network. We need to have more information on the international cooperation such as ICH, ICMRA, IPRF, IGDRP, TTIP."

The full interview is available to read in the event download centre at www.pharmacovigilance-event.co.uk/PrLog

The keynote address by Doris Stenver will discuss the latest PRAC updates and signal management processes in the UK.

"I am Chief Medical Officer at the Danish Health and Medicines Authority and member of the Pharmacovigilance Risk Assessment Committee (PRAC); I am invited to give an update on activities in the PRAC, where I will focus on developments within risk management and risk minimization, signal management and communication" - Doris Irene Stenver, Chief Medical Officer, Danish Health and Medicines Authority, Member of PRAC.

Other featured speakers include:

• Graeme Ladds, CEO, Director of Operations, Pharmacovigilance, PharSafer Associates

• Dr. Pipasha Biswas, Executive Director & QPPV, Symogen

• Dr Kashif Sheikh, Senior Safety Surveillance Advisor, Novo Nordisk

• Dr. Michael Merz, Chair Investigative Liver Expert Team, Novartis Institute for Biomedical Research

• Shelley Gandhi, Director of Pharmacovigilance and Drug Safety, NDA Group

Visit the website to see the full speaker line-up for 2015
Further information and a brochure is available online at www.pharmacovigilance-event.co.uk/PrLog

Pharmacovigilance, Drug Safety & Risk Management
11-12 May 2015
Holiday Inn Regents Park Hotel, London UK
www.pharmacovigilance-event.co.uk/PrLog

---END---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Media Contact
Teri Arri
tarri@smi-online.co.uk
+44 (0) 20 7827 6162
End
Source: » Follow
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Tags:Pharmacovigilance, Drug Safety, Risk Management, Pharmaceutical, Medical
Industry:Event, Medical
Location:London - England - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share